HCA Healthcare Inc. ($HCA) Stock Forecast: Down 1.6% Today

What is HCA Healthcare Inc.?

HCA Healthcare (HCA) is a leading U.S. hospital operator that recently reported mixed quarterly results, with an earnings per share miss but revenue beat. The company declared a quarterly dividend of $0.78 per share and continues to attract attention from institutional investors.

Why is HCA Healthcare Inc. going down?

HCA stock is down 1.6% on May 11, 2026 14:55

• Despite boosted Q2 EPS estimates, HCA Healthcare experienced a bearish movement, possibly due to profit-taking after recent price increases.
• The increase in institutional investors acquiring more shares could have initially driven positive sentiment, but the subsequent trimming of stakes by another investor might have raised concerns among investors.
• The strong first-quarter results and dividend hike reported by HCA Healthcare could have initially driven investor interest, but the overall mixed quarterly performance may have led to profit realization and contributed to the bearish movement.
• The market's reaction suggests that while the company's fundamentals remain strong, investors may be cautious about the stock's short-term outlook, leading to the bearish movement today.

HCA Price Chart

HCA Technical Analysis

HCA News

HCA Healthcare Q2 EPS Estimate Boosted by Zacks Research

Zacks Research has increased its Q2 2026 EPS estimate for HCA Healthcare to $7.27, up from $7.21, and also adjusted several longer-term forecasts, including FY2026 EPS to $29.82. Despite some cuts to future period estimates, the overall analyst sentiment remains positive with a "Moderate Buy" rating and an average price target of $517.82, suggesting significant upside potential. HCA Healthcare recently reported Q1 earnings that slightly missed EPS estimates but beat revenue expectations, and declared a quarterly dividend of $0.78 per share.

https://www.marketbeat.com/instant-alerts/hca-healthcare-q2-eps-estimate-boosted-by-zacks-research-2026-05-11/

JSF Financial LLC Takes Position in HCA Healthcare, Inc. $HCA

JSF Financial LLC has initiated a new position in HCA Healthcare, acquiring 2,628 shares valued at approximately $1.23 million. This comes as HCA Healthcare reported quarterly earnings slightly below consensus but revenue that edged above estimates. Wall Street maintains a "Moderate Buy" consensus for HCA, with an average target price of $517.82, despite recent price target adjustments by some analysts.

https://www.marketbeat.com/instant-alerts/filing-jsf-financial-llc-takes-position-in-hca-healthcare-inc-hca-2026-05-10/

F m Investments LLC Trims Stake in HCA Healthcare, Inc. $HCA

F m Investments LLC significantly reduced its stake in HCA Healthcare by 50.6% in the fourth quarter, now holding 10,245 shares valued at $4.78 million. Despite this trimming, Wall Street analysts generally maintain a "Moderate Buy" rating for HCA with an average target price of $517.82, though some long-term earnings estimates have been lowered. The company recently reported quarterly EPS of $7.15 on revenue of $19.11 billion and declared a $0.78 quarterly dividend.

https://www.marketbeat.com/instant-alerts/filing-f-m-investments-llc-trims-stake-in-hca-healthcare-inc-hca-2026-05-10/

Ethic Inc. Buys 5,781 Shares of HCA Healthcare, Inc. $HCA

Ethic Inc. increased its stake in HCA Healthcare by 35% in the fourth quarter, purchasing 5,781 additional shares, bringing its total holdings to 22,310 shares valued at approximately $10.4 million. Despite HCA reporting mixed quarterly results with an EPS miss but revenue beat, analysts maintain a generally positive outlook with an average target price of $517.82. The company also declared a quarterly dividend of $0.78 per share and continues to attract attention from institutional investors while facing some insider selling.

https://www.marketbeat.com/instant-alerts/filing-ethic-inc-buys-5781-shares-of-hca-healthcare-inc-hca-2026-05-10/

HCA Healthcare stock (US40412C1018): Earnings beat and dividend hike drive investor interest

HCA Healthcare (US40412C1018) reported strong first-quarter 2026 results, exceeding analyst expectations for earnings per share and revenue. The company also announced an increase in its quarterly dividend, signaling continued strength in U.S. hospital volumes and pricing power. This performance reinforces HCA Healthcare's position as a leading U.S. hospital operator and offers investors exposure to the growing healthcare spending market.

https://www.ad-hoc-news.de/boerse/news/ueberblick/hca-healthcare-stock-us40412c1018-earnings-beat-and-dividend-hike-drive/69298161

Trending Today

Wheat ($WHEAT) Commodity Forecast: Up 6.3% Today

SBA Communications Corporation ($SBAC) Stock Forecast: Down 1.8% Today

Zebra Technologies Corporation ($ZBRA) Stock Forecast: Up 10.6% Today

Corning Incorporated ($GLW) Stock Forecast: Down 5.1% Today

Huntington Ingalls Industries Inc. ($HII) Stock Forecast: Up 5.1% Today

Tandem Diabetes Care, Inc. ($TNDM) Stock Forecast: Up 5.0% Today

Opendoor Technologies Inc. ($OPEN) Stock Forecast: Down 5.6% Today

Centene Corporation ($CNC) Stock Forecast: Up 5.4% Today

Advanced Micro Devices Inc. ($AMD) Stock Forecast: Down 5.1% Today

Micron Technology Inc. ($MU) Stock Forecast: Down 7.0% Today

HCA Healthcare Inc. Price History

11.01.2026 - HCA Stock was up 5.0%

• The reduction in stake by Prospera Financial Services Inc. did not deter other institutional investors like Norges Bank and Viking Global Investors LP from increasing their positions in HCA, indicating confidence in the company's growth prospects.
• HCA's robust financial performance, beating EPS estimates, issuing optimistic guidance, and raising its dividend, likely contributed to the bullish movement in its stock price.
• The upcoming community meetings regarding HCA Mission Health System may have also generated positive sentiment among investors, showcasing transparency and accountability in the company's operations.
• HCA's strategic focus on expanding market presence, enhancing digital capabilities, and managing risks highlighted in its SEC 10-K report further solidifies investor confidence in the company's long-term sustainability and growth potential.

11.04.2026 - HCA Stock was down 1.6%

• Despite boosted Q2 EPS estimates, HCA Healthcare experienced a bearish movement, possibly due to profit-taking after recent price increases.
• The increase in institutional investors acquiring more shares could have initially driven positive sentiment, but the subsequent trimming of stakes by another investor might have raised concerns among investors.
• The strong first-quarter results and dividend hike reported by HCA Healthcare could have initially driven investor interest, but the overall mixed quarterly performance may have led to profit realization and contributed to the bearish movement.
• The market's reaction suggests that while the company's fundamentals remain strong, investors may be cautious about the stock's short-term outlook, leading to the bearish movement today.

24.03.2026 - HCA Stock was down 8.2%

• HCA Healthcare saw a decline in its stock price despite posting strong first-quarter financial results.
• Factors contributing to the stock's drop include weak volume trends, specifically lower admissions and emergency room visits related to respiratory issues.
• Concerns about the company's valuation arose following mixed Q1 results – a miss in diluted EPS estimates but a beat in revenue expectations.
• Investor sentiment may have been influenced by the company's leverage and insider selling, as per observations by GuruFocus.

24.03.2026 - HCA Stock was down 9.1%

• Despite reporting a 4.3% increase in revenues and a 10.9% rise in diluted EPS, HCA Healthcare's stock took a hit due to lower respiratory-related admissions and the impact of a winter storm on patient volumes.
• The company's reaffirmation of its 2026 guidance, including expectations of 2-3% volume growth for the remainder of the year, was not enough to offset concerns about the softer respiratory season and dynamic environment.
• Investors may have reacted negatively to the mixed same-facility volume trends and the ongoing challenges related to health insurance exchanges and Medicaid conversions, leading to the bearish movement in HCA's stock price today.

24.03.2026 - HCA Stock was down 9.9%

• Despite reporting first-quarter results that slightly beat analyst expectations, HCA Healthcare experienced a significant bearish movement, dropping nearly 8%.
• The stock's decline can be attributed to weak volume trends, including a notable decrease in respiratory-related admissions and emergency room visits, as well as the absence of typical seasonal increases.
• Concerns about the company being overvalued, highlighted by GuruFocus, with a GF Value of $431.18 versus the current price of $474.03, might have also contributed to the bearish sentiment.
• The market's reaction could also be influenced by the mixed Q1 2026 results, with diluted EPS missing estimates but revenue beating expectations, leading to uncertainty among investors about the company's future performance.

27.00.2026 - HCA Stock was up 6.5%

• Strong Q4 earnings were reported by HCA Healthcare, surpassing analyst projections and resulting in a bullish trend in its stock price.
• Investor enthusiasm was fueled by the company's announcement of a new $10 billion share repurchase plan and an uptick in the quarterly dividend.
• Despite a slight miss in revenue expectations for Q4, HCA Healthcare's focus on profitability, sustained EPS growth, and ambitious financial objectives for 2026 provided a favorable perspective for investors.
• Confidence in HCA Healthcare's performance and future prospects was bolstered by Markel Group Inc.'s increased stake and the overall positive sentiment from analysts and institutional investors.

17.02.2026 - HCA Stock was down 5.2%

• An increase in holdings by Mercer Global Advisors Inc. ADV in HCA Healthcare could reflect confidence in the company's future prospects, although market sentiment may have been influenced by various factors.
• Despite HCA Healthcare's strong performance and strategic investments, notable insider selling activities in the healthcare sector, involving CEOs and Directors of companies like ResMed Inc. and Tenet Healthcare Corporation, might have had a negative impact on investor sentiment.
• Analysts supporting a "Moderate Buy" rating for HCA Healthcare amidst insider selling and institutional adjustments present a mixed outlook, potentially contributing to the stock's bearish movement.
• HCA Healthcare's emphasis on AI-driven efficiencies and disciplined capital deployment for future growth, highlighted in industry conferences, contrasts with insider selling trends in the sector, complicating market dynamics and potentially affecting the stock price adversely.

27.00.2026 - HCA Stock was up 7.1%

• Strong Q4 earnings were reported by HCA Healthcare, surpassing analyst expectations and resulting in a bullish movement in the stock.
• Investor confidence was further boosted by the company's announcement of a new $10 billion share repurchase program and an increased quarterly dividend.
• Despite a cautious revenue guidance for 2026, HCA Healthcare's commitment to profitability and continued EPS growth highlighted its ability to effectively navigate a stable operating environment.
• The positive market sentiment towards HCA Healthcare was evident through increased institutional investments, with entities like Markel Group Inc. acquiring additional shares, indicating a growing confidence in the company's performance and future prospects.

28.00.2026 - HCA Stock was down 5.3%

• Despite reporting strong Q4 earnings, HCA Healthcare's stock experienced a bearish movement as the cautious revenue guidance for 2026 fell below analyst expectations.
• The announcement of a new $10 billion share repurchase program and an increased quarterly dividend were not enough to offset concerns about the company's future revenue growth.
• The market may be reacting negatively to economic headwinds, which could impact HCA's revenue projections for the upcoming year.
• The bullish sentiment on outpatient expansion might not have been sufficient to reassure investors about the company's overall growth prospects, leading to the bearish movement in the stock price.

11.01.2026 - HCA Stock was up 6.6%

• Unusual options activity on HCA Healthcare, with predominantly bullish trades and a price window of $350.0 to $560.0, signals a positive sentiment among investors, propelling the stock price higher.
• The reduction in stake by Prospera Financial Services Inc. may have initially raised concerns, but increased positions by other institutional investors and robust quarterly earnings report surpassing EPS estimates and raising dividends have reassured investors and fueled the bullish trend.
• The upcoming community meetings to discuss updates on HCA Mission Health System could be viewed as a favorable move towards transparency and accountability, potentially enhancing investor confidence in HCA Healthcare's operations and future outlook.

12.01.2026 - HCA Stock was up 5.7%

• A notable reduction in LSV Asset Management's stake in HCA Healthcare by 2.9% initially raised concerns but did not dampen market sentiment due to the company's robust financial performance.
• The increase in earnings estimates for HCA Healthcare by Zacks Research, along with a "Hold" rating, indicates rising confidence in the company's future prospects, contributing to the positive market movement.
• HCA's stock hitting a new 52-week high and receiving an "Outperform" rating from analysts reflects investors' optimism about its ongoing growth and profitability.
• Despite a slight decrease in the Q1 2026 EPS estimate and an insider share sale causing some negative sentiment, the overall positive news of strong earnings, dividend increase, and strategic expansion into outpatient services drove HCA's stock to new highs.

12.02.2026 - HCA Stock was up 2.7%

• HCA Healthcare is a leading healthcare services provider in the US, offering a wide range of medical services to patients.
• The overall market sentiment for HCA Healthcare has been positive, with strong bullish movement today.
• Franklin Resources Inc. reducing its stake in HCA Healthcare did not hinder the company's performance, as it surpassed quarterly EPS expectations, raised its dividend, and received a "Moderate Buy" rating from analysts, leading to increased investor confidence.
• First Trust Advisors LP increasing its shares in HCA Healthcare suggests growing institutional interest, which has further bolstered market sentiment.
• The optimistic prospects for HCA Healthcare, coupled with the rise in quarterly dividend, likely contributed to the surge in the stock price today.